PharmaCyte Biotech, Inc. (PMCB)
NASDAQ: PMCB · Real-Time Price · USD
0.8190
-0.0290 (-3.42%)
At close: Jan 30, 2026, 4:00 PM EST
0.8400
+0.0210 (2.56%)
After-hours: Jan 30, 2026, 6:35 PM EST
PharmaCyte Biotech Employees
PharmaCyte Biotech had 2 employees as of April 30, 2025. The number of employees did not change compared to the previous year.
Employees
2
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$3,816,659
Market Cap
8.30M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Apr 30, 2025 | 2 | 0 | - |
| Apr 30, 2024 | 2 | 0 | - |
| Apr 30, 2023 | 2 | -2 | -50.00% |
| Apr 30, 2022 | 4 | 0 | - |
| Apr 30, 2021 | 4 | 0 | - |
| Apr 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Apr 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Apr 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Apr 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Apr 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| BiomX | 57 |
| SeaStar Medical Holding | 19 |
| BioVie | 13 |
| VivoSim Labs | 13 |
| Kiora Pharmaceuticals | 12 |
| XTL Biopharmaceuticals | 10 |
| MetaVia | 9 |
| Alzamend Neuro | 7 |
PMCB News
- 2 months ago - PharmaCyte Biotech Successfully Monetizes Femasys Stake, Strengthening Cash Position and Underscoring Strategic Capital Deployment - Business Wire
- 5 months ago - PharmaCyte Biotech, Inc. Increases Stake in TNF Pharmaceuticals Around Recent License for Breakthrough Light Speed Computing Platform for Use in Cryptocurrency Applications - Business Wire
- 5 months ago - PharmaCyte Biotech, Inc. Announces Closing of $7 Million Financing - Business Wire
- 5 months ago - PharmaCyte Biotech, Inc. Announces $7 Million Capital Raise Led by Existing Investors - Business Wire
- 1 year ago - MyMD Pharmaceuticals Secures Strategic Investments - Business Wire
- 1 year ago - PharmaCyte Biotech Makes $7 Million Strategic Investment in MyMD, A Biopharmaceutical Company Focused on Inflammatory Disease - Business Wire
- 2 years ago - PharmaCyte Biotech Acquires $5 Million Stake in Emerging Women's Health Innovator Femasys, Inc. - Business Wire
- 2 years ago - PharmaCyte Biotech Provides Corporate Update on Cell-in-a-Box Technology - Business Wire